Vonafexor
Vonafexor (EYP001) is a potent and selective agonist of the farnesoid X receptor (FXR/NR1H4) . It demonstrates anti-hepatitis B virus (HBV) activity and has been investigated in both in vitro assays and in vivo preclinical models for chronic liver diseases, including HBV infection.
Product Specifications
CAS Number
1192171-69-9
Product Name Alternative
Vonafexor, EYP 001, EYP001, EYP-001, FXR, Inhibitor, HBV, Hepatitis B virus, inhibit, NR1H4, PLX007, PLX-007, PLX 007, pxl007
Field of Research
Infectious Disease & Virology, Metabolism Research
Purity
98.74% (May vary between batches)
Solubility
DMSO:22.5 mg/mL (45.94 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.08 mM)
Smiles
OC (=O) c1cc2c (Cl) c (ccc2o1) N1CCN (CC1) S (=O) (=O) c1c (Cl) cccc1Cl
Molecular Formula
C19H15Cl3N2O5S
Molecular Weight
489.76
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2234003 1.0 µg DNA
SNORD87 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
bs-15320R-Cy5.5 100 µL
C9orf172 Polyclonal Antibody, Cy5.5 Conjugated
Sign In for Pricing
View Details